載入...
European Cancer Congress 2015
The European Cancer Congress, which attracts a range of European cancer groups, reflected intense interest in immunotherapies. we review key sessions, including three on the anti-programmed death-1 agent nivolumab, each in a different disease setting.
Na minha lista:
| 發表在: | P T |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MediMedia USA, Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634349/ https://ncbi.nlm.nih.gov/pubmed/26609211 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|